BlackRock Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$20.6M Buy
933,771
+156,285
+20% +$3.21M 0.02% 669
2016
Q3
$12.4M Buy
777,486
+3,674
+0.5% +$42K 0.02% 869
2016
Q2
$6.38M Buy
773,812
+654,834
+550% +$5.83M 0.01% 1267
2016
Q1
$833K Sell
118,978
-347,788
-75% -$1.75M ﹤0.01% 2607
2015
Q4
$2.5M Sell
466,766
-461,167
-50% -$2.95M ﹤0.01% 1923
2015
Q3
$6M Buy
+927,933
New +$9.71M 0.01% 1249

Other funds holding CC

BlackRock Investment Management's CC Position: Q4 2016 in Review

BlackRock Investment Management increased its Chemours (CC) stake by 20% in Q4 2016, buying an estimated $3.21M and bringing the position to 933,771 shares worth $20.6M. The position accounts for 0.02% of the portfolio, ranked #669.

BlackRock Investment Management first reported a position in CC in Q3 2015 and has held it in 6 quarters since. 417 funds tracked by Wall St. Rank hold CC as of Q4 2016.

  • BlackRock Investment Management held 933,771 shares of Chemours worth $20.6M as of Q4 2016.
  • BlackRock Investment Management bought 156,285 Chemours shares in Q4 2016, an estimated $3.21M.
  • Chemours made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #669 holding.
  • BlackRock Investment Management first reported a position in Chemours in Q3 2015 and has held it in 6 quarters since.
  • 417 funds tracked by Wall St. Rank held Chemours as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.